The Power of Semaglutide in Clinical Trials The evidence supporting semaglutides role in reversing prediabetes is compelling
This is not up for debate
The greater magnitudes of bodyweight reduction seen in this trial, as well as the improvements in cardiovascular risk factors and glucose control, can have beneficial effects on health goals in clinical practice. In the STEP UP T2D trial, a higher semaglutide dose resulted in an average bodyweight reduction of 13.2%, compared to 10.4% for the standard dose and 3.9% for the placebo
If you want to try semaglutide for one month before deciding to continue, or if you anticipate needing to pause for surgery, travel, or other reasons shortly after starting, providers offering more flexible subscription structures are a better fit
Other situations requiring prompt medical contact include signs of allergic reactions (difficulty breathing, swelling of the face or throat, severe rash)call 911 for severe allergic reactionssymptoms of thyroid tumors (a lump or swelling in the neck, hoarseness, difficulty swallowing), or signs of kidney problems (decreased urination, swelling in legs or feet, unusual fatigue)